australian personal importation scheme peptides cjc 1295 ipamorelin CJC-1295 Peptide combination Guide This is a joint statement
This is a joint statement from the TGA and Australia's Chief Medical Officer on concerns regarding the public health risks associated with unapproved peptide products. Australia's health leaders are increasingly concerned about CJC 1295 Ipamorelin Benefits, Side Effects, and Cost: The Complete Patient Guide Perfect B Since January 2026, there have been six cases of acute liver toxicity associated with unapproved peptide products labelled Retatrutide in Australia. These toxic effects may be linked to a contaminant in the CJC 1295 Ipamorelin: FDA Status, Compounding Ban & 2026
Pay in 4 interest-free payments of $7.08 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 30 - Aug 4

